Search

Showing 1 - 24 of 107 results

Previous| 1 | 2 | 3 ...5 |Next


Radioligand Therapy Plus Pembrolizumab May Benefit Patients with Advanced Prostate Cancer News

Radioligand Therapy Plus Pembrolizumab May Benefit Patients with Advanced Prostate Cancer

Immune checkpoint inhibitors have demonstrated limited efficacy in treating prostate cancer. Efforts to improve outcomes with combination therapies have mostly failed to demonstrate improvements compared to other types of cancer.
Study Finds Significant Chemical Exposures in Women With Cancer News

Study Finds Significant Chemical Exposures in Women With Cancer

In a sign that exposure to certain endocrine-disrupting chemicals may be playing a role in cancers of the breast, ovary, skin and uterus, researchers have found that people who developed those cancers have significantly higher levels of these chemicals in their bodies.
Inclusion of New Risk Factors Can Improve Prediction of Invasive Breast Cancer News

Inclusion of New Risk Factors Can Improve Prediction of Invasive Breast Cancer

UCSF researchers update Breast Cancer Surveillance Consortium model to account for BMI and other familial risk factors.
New Keys to Cancer Care: How 2023 Findings Impact Treatment Decisions Video

New Keys to Cancer Care: How 2023 Findings Impact Treatment Decisions

These four collaborative talks from UCSF and John Muir Health specialists shine a light on recent study results that should inform treatment planning for patients with a variety of GI, breast, lung and blood cancers.
UCSF Cancer Researcher Thomas Martin Receives $4.6 million CIRM Grant News

UCSF Cancer Researcher Thomas Martin Receives $4.6 million CIRM Grant

UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T cell therapy for multiple myeloma, the second most common malignancy among blood cancers. 
Can Gene Expression Predict if a Brain Tumor Is Likely to Grow Back? News

Can Gene Expression Predict if a Brain Tumor Is Likely to Grow Back?

Screening tumors using this new approach could change the course of treatment for nearly 1 in 3 people with meningioma, the most common form of brain tumor diagnosed in 42,000 Americans each year.
Improving Prediction of Advanced Breast Cancer Among Women of Different Races and Ethnicities News

Improving Prediction of Advanced Breast Cancer Among Women of Different Races and Ethnicities

While regular screenings may decrease the chance of diagnosis of advanced breast cancer in some women and lead to a 20% reduction in breast cancer mortality, other women will be diagnosed with advanced breast cancer despite screening at regular intervals.
UCSF Health’s Eric Small, MD, Elected ASCO President for 2025-2026 Term News

UCSF Health’s Eric Small, MD, Elected ASCO President for 2025-2026 Term

The American Society of Clinical Oncology (ASCO) has elected Eric J. Small, MD, FASCO, to serve as its president for the term beginning in June 2025.
Cancer Immunotherapy Toxicity Evaluation (CITE) Program Document

Cancer Immunotherapy Toxicity Evaluation (CITE) Program

UCSF Health’s new Cancer Immunotherapy Toxicity Evaluation (CITE) Program is a valuable resource for both patient care and provider consults.
A Novel Approach Towards a Vaccine for Relapsing Acute Myeloid Leukemia: Q&A with Dr. Karin Gaensler News

A Novel Approach Towards a Vaccine for Relapsing Acute Myeloid Leukemia: Q&A with Dr. Karin Gaensler

There is a major clinical unmet need for effective and safe therapies to increase progression-free and overall survival in older individuals with leukemia whose prognosis is grim.
UCSF Health Cancer Services Earns National Accreditation from the Commission on Cancer of the American College of Surgeons News

UCSF Health Cancer Services Earns National Accreditation from the Commission on Cancer of the American College of Surgeons

The UCSF cancer program has been continuously accredited by the CoC since 1933, demonstrating its commitment to the best outcomes possible for its cancer patients.
Scientists Discover a Deadly Brain Cancer’s Hidden Weakness News

Scientists Discover a Deadly Brain Cancer’s Hidden Weakness

The difficult-to-treat brain cancer glioblastoma steals a person’s mental faculties as it spreads, yet the tumor’s insidious ability to infiltrate distant networks in the brain could also prove its undoing.
UCSF Surgical Oncologists Providing New Treatment Options for Patients with Metastatic Gastrointestinal Cancers News

UCSF Surgical Oncologists Providing New Treatment Options for Patients with Metastatic Gastrointestinal Cancers

UCSF Health’s surgical oncology team is a Bay Area leader in an innovative chemotherapy infusion pump used to treat patients with widely metastatic colorectal and bile duct cancers that have spread to the liver and are no longer considered operable.
Can Lymph Nodes Boost the Success of Cancer Immunotherapy? News

Can Lymph Nodes Boost the Success of Cancer Immunotherapy?

New data from a clinical trial show therapies may activate lymph nodes to produce tumor-tackling T cells.
First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers News

First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers

The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated metastatic or unresectable biliary tract cancer, according to results from the phase III KEYNOTE-966 clinical trial.
Cardio-Oncology & Immunology: Specialized Cardiovascular Care for Cancer Patients Document

Cardio-Oncology & Immunology: Specialized Cardiovascular Care for Cancer Patients

Led by a multidisciplinary team of specialists and researchers, our program optimizes the cardiovascular health of cancer patients and cancer survivors.
Patients With Detectable PSA After Radical Prostatectomy Have Good Long-Term Outcomes, UCSF Researchers Find News

Patients With Detectable PSA After Radical Prostatectomy Have Good Long-Term Outcomes, UCSF Researchers Find

Patients with a detectable prostate-specific antigen (PSA) after radical prostatectomy (RP) may have excellent long-term outcomes, according to two retrospective studies conducted by UCSF researchers.
UCSF Surgical Oncologists Present Clinical Findings at International Conference News

UCSF Surgical Oncologists Present Clinical Findings at International Conference

The latest advances in surgical cancer care and research were showcased at the Society of Surgical Oncology’s (SSO) Annual Meeting, the International Conference on Surgical Cancer Care. The meeting was held in Boston, from March 22 – 25, 2023.
Advances in Breast Cancer Care: Individualized Screening, Treatments and Follow-Up Video

Advances in Breast Cancer Care: Individualized Screening, Treatments and Follow-Up

Karen Goodwin, DO, covers everything from how to answer patients’ questions on mammogram frequency to how to counsel them on breast cancer prevention.
Killing Pancreatic Cancer with T Cells that Turbocharge Themselves News

Killing Pancreatic Cancer with T Cells that Turbocharge Themselves

Novel Immunotherapy Pumps Out Cancer-Killing Cytokines Only Inside the Tumor
Breast Cancer Risk Calculator Can Assess Risk of Advanced Breast Cancer News

Breast Cancer Risk Calculator Can Assess Risk of Advanced Breast Cancer

Upcoming Conference to Focus on Breast Density and Prediction of Advanced and Interval Breast Cancer Risk
UCSF and I-SPY 2 Breast Cancer Researchers Develop Newly Redefined Breast Cancer Response Subtypes News

UCSF and I-SPY 2 Breast Cancer Researchers Develop Newly Redefined Breast Cancer Response Subtypes

Research scientists and statisticians from UC San Francisco have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients.
How AI Found the Words to Kill Cancer Cells News

How AI Found the Words to Kill Cancer Cells

Predictive model allows researchers to encode commands for cells to carry out.
“CAR Pooling” Screens Identify Most Effective Cancer Immunotherapy Cells News

“CAR Pooling” Screens Identify Most Effective Cancer Immunotherapy Cells

New approach by UCSF researchers analyzes how well different re-engineered T cells work against cancer.

Showing 1 - 24 of 107 results

Previous| 1 | 2 | 3 ...5 |Next